The Food and Drug Administration last week issued an emergency use authorization for the Battelle Decontamination System for decontaminating compatible N95 and equivalent respirators for reuse by health care personnel.

This message includes information on the Battelle Critical Care Decontamination System (CCDS)TM and how it could help your organization access additional quantities of N95 and equivalent respirators. Please share this email with your COVID-19 response team.

The Battelle Institute is operating sites across the U.S. to increase the inventory of N95 and equivalent respirators. At present, Battelle hydrogen peroxide gas decontamination units are available for rapid intake and reprocessing of up to 80,000 respirators per day in:

• New Jersey
• New York
• Ohio (also serving Michigan and Indiana)
• Washington

The Battelle CCDSTM is grounded on an FDA study completed following a 2016 contagion. The study validated that CCDSTM technology successfully decontaminated N95 masks and that the mask could withstand processing 20 times with no degradation of filtration performance. Battelle is conducting additional research to validate that other materials, such as surgical masks and ventilator components, can withstand the process and continue to function as designed following multiple decontamination cycles.

To learn more about how to enroll in this program, please contact Battelle directly by clicking here and complete the Battelle CCDSTM inquiry form.